About
Diagnostic
Areas of Focus
Categories
DiagnosticsBiologics & Biopharmaceutical
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
99
By Phase
NA: 2PHASE3: 2PHASE2: 1
By Status
COMPLETED: 5
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05046899Lead Sponsor
Investigation With BiopH+Psoriasis Medical Bath in Subject With Mild to Moderate Plaque Psoriasis.
NACompleted
25 participants
Started: Sep 14, 2021 · Completed: Jun 13, 2022
NCT04265521Lead Sponsor
Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet
NACompleted
25 participants
Started: Mar 3, 2020 · Completed: Jun 25, 2020
NCT03512314Lead Sponsor
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency As Open Label Extension
PHASE3Completed
11 participants
Started: Jan 24, 2018 · Completed: May 8, 2024
NCT03113760Lead Sponsor
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency
PHASE3Completed
15 participants
Started: Jul 21, 2017 · Completed: Nov 2, 2023
NCT02398435Lead Sponsor
Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease
PHASE2Completed
23 participants
Started: Feb 28, 2015 · Completed: Jul 31, 2016
Locations (1)
Headquarters
Lausanne, Switzerland
Map
Loading map...